SAN DIEGO — Gen-Probe, today announced three changes to its leadership team in support of its future growth. Brian B. Hansen has been promoted to senior vice president, global sales and service. Michael J. Watts has been appointed vice president of LIFECODES and Prodesse; and Albert S. Kildani has joined the Company as senior director, investor relations and corporate communications.

“These changes further strengthen Gen-Probe’s ability to drive profitable, global growth, and reflect our ability to retain and attract talented individuals to our team,” said Carl Hull, Gen-Probe’s chairman and chief executive officer. “Brian’s efforts have been critical to our commercial success over the last six years and this promotion reflects his many accomplishments in helping us build a world-class sales and customer support organization. Mike has done an exceptional job leading our investor relations program while communicating the Company’s strategies and results to the markets credibly and consistently. A number of us have worked with Al over the years in various capacities and he has known the Company and its industry for many years, which will make for a smooth transition as he replaces Mike.”

Hansen has been with Gen-Probe for over six years and has led the Company’s highly respected sales and service organization in the United States in a number of increasingly responsible roles during that time. In his new position, he will oversee the continued geographic expansion of Gen-Probe’s commercial organization throughout the world.

Watts has managed Gen-Probe’s investor relations and corporate communications efforts for over eight years. In his new role, he will lead the Company’s efforts to profitably grow its recently acquired business units focusing on transplant diagnostics and infectious disease testing.

Kildani joins Gen-Probe after a 14-year career on Wall Street as a sell-side research analyst, investment banker, and buy-side analyst in the healthcare space with a focus on the molecular diagnostics industry. Al has strong existing relationships with many of the Company’s institutional shareholders and research analysts.

About Gen-Probe

Gen-Probe is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. Gen-Probe is headquartered in San Diego and employs approximately 1,400 people. For more information, go to https://www.gen-probe.com.